[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fvs7oQHZi49f0IlEOxTyAgkTefyrn-yVDBFJrklwmNsA":8,"$fvEenorhhQpxI5dT-WL4AxONwgnCZYCE6oA3DSk6T5vg":55,"$fAphZf0AXrLVu_tKmM94FBxFGB4HhLjONw7w4FAihNuk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67011,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"卵巢癌IV期治疗的科学指南：白蛋白紫杉醇与贝伐珠单抗的应用","","https://ystcdn.venuertc.com/venue/AI/4a3cd181-1be5-452e-b0b6-299d310a44a7.jpg","\u003Cdiv id=\"material_title\" class=\"ovarian-guide-title\">\n  卵巢癌IV期治疗的科学指南：白蛋白紫杉醇与贝伐珠单抗的应用\n\u003C/div>\n\n\u003Cdiv class=\"ovarian-guide-section bg-soft\" style=\"background: linear-gradient(90deg, #f9fafb 0%, #e3dde9 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">开篇：为什么要关注用药细节？\u003C/h2>\n  \u003Cp>\n    说起来，白蛋白紫杉醇和贝伐珠单抗是常见的抗肿瘤药物，主要在专业治疗方案中使用。很多人熟悉这两种药，但用药的关键细节其实很容易被忽略。今天我们要聊的，是这两类药品在维持性治疗中的7个关键用药细节，包括用药时间、剂型特点、相互作用、特殊人群用药、不良反应处理等，帮助大家增强用药安全感。💊\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 01 剂型与服用方式 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img1\" style=\"background: linear-gradient(90deg, #e7eee2 0%, #f3e7e0 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 白蛋白紫杉醇与贝伐珠单抗：剂型与应用技巧 🧬\u003C/h2>\n  \u003Cp>\n    白蛋白紫杉醇是一种抗肿瘤药，常见剂型为注射用粉末，配制后静脉滴注。贝伐珠单抗也是注射剂，属于人源化单抗，静脉给药。两者需严格遵循配制标准：\u003Cbr>\n    \u003Cb>白蛋白紫杉醇\u003C/b>常用剂量为180mg，分为第1天和第8天给药；\u003Cbr>\n    \u003Cb>贝伐珠单抗\u003C/b>常见用量为400mg，每3周一次。\u003Cbr>\n    \u003Cspan class=\"ovarian-guide-important\">正确做法：\u003C/span>两种药物均只可在医疗机构静脉滴注，由专业人员操作。自行调配、注射极易引发严重反应，切勿自行用药。\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>给药前需复核药品批号、外观及有效期。\u003C/li>\n    \u003Cli>仅能通过点滴方式缓慢输注，不可推注。\u003C/li>\n    \u003Cli>配药后需在规定时限内用完，避免药液变质。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003C!-- 02 药理作用及机制 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img2\" style=\"background: linear-gradient(90deg, #e8eef5 0%, #ecfaf1 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 作用机制简述：怎么发挥抗肿瘤效果？🔬\u003C/h2>\n  \u003Cp>\n    白蛋白紫杉醇通过干扰微管的组装与分裂，阻断细胞增殖，属于细胞周期抑制剂。贝伐珠单抗作为VEGF单抗，主要通过抑制新生血管生成，减少肿瘤供血。两者采用联合或序贯方案以提高治疗效果。\u003Cbr>\n    \u003Cspan class=\"ovarian-guide-important\">需要注意：\u003C/span>两药协同作用，可能增强副作用，因此方案制定需由临床医生评估。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 03 用药时间与管理要求 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img3\" style=\"background: linear-gradient(90deg, #f2f5fb 0%, #f7efe6 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用药时间与周期管理⏰\u003C/h2>\n  \u003Cp>\n    正确的给药周期对于效果有决定性影响。以实际案例为例：\u003Cbr>\n    \u003Cb>一位67岁女性患者连续6年接受白蛋白紫杉醇与贝伐珠单抗维持性治疗，每周期严格控制在21天，全程由护士管理静脉滴注。\u003C/b>\n    \u003Cbr>\n    \u003Cspan class=\"ovarian-guide-important\">用药安排：\u003C/span>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>白蛋白紫杉醇第1天、第8天滴注，剂量必须按体重和体表面积算。\u003C/li>\n    \u003Cli>贝伐珠单抗每隔21天注射一次，需提前预约确保药品供应。\u003C/li>\n    \u003Cli>每次用药前均需抽血复查肝肾功能、血细胞计数。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    服药时间不规律或漏服，可能导致疗效下降和不良反应发生率升高。若漏服，请及时联系医护人员，切勿自行补药或更改剂量。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 04 药物相互作用和配伍问题 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img4\" style=\"background: linear-gradient(90deg, #edf2f5 0%, #f0efe7 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用与配伍要求⚠️\u003C/h2>\n  \u003Cp>\n    这两种药在联合用药时，要特别考虑与其他药物的相互作用。白蛋白紫杉醇通过肝脏CYP酶代谢，如果同时使用强效CYP3A4抑制剂（如酮康唑、红霉素），可能增加毒性。而贝伐珠单抗与抗高血压药、抗凝药同用需谨慎，增加出血风险或高血压概率。\n    \u003Cbr>\n    \u003Cspan class=\"ovarian-guide-important\">正确做法：\u003C/span>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>如需同时用其他化疗药、激素或止吐药，需由医生统筹调整方案。\u003C/li>\n    \u003Cli>避免与潜在肝脏酶抑制剂、诱导剂同用，尤其是抗生素、抗癫痫药物。\u003C/li>\n    \u003Cli>联合用药期间，如出现异常出血、血压升高，立即停药并就医。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    临床数据表明，联合用药的不良反应发生率可达40%以上（Burger et al., 2011），安全监测至关重要。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 05 特殊人群用药注意事项 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img5\" style=\"background: linear-gradient(90deg, #f9f9ea 0%, #e7f3ee 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药：老年人、肝肾功能异常等🧓\u003C/h2>\n  \u003Cp>\n    不同人群对这两类药品的代谢和耐受性会有很大不同。举例来说：\u003Cbr>\n    \u003Cb>临床上，老年患者用药时往往需适当降低紫杉醇剂量，贝伐珠单抗则密切监测心血管与肾功能。\u003C/b>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>\n      老年患者建议起始剂量减量，观察1-2个周期后再调整。\n    \u003C/li>\n    \u003Cli>\n      肾功能不全者，贝伐珠单抗必须谨慎使用，必要时停止治疗。\n    \u003C/li>\n    \u003Cli>\n      孕妇和哺乳期女性禁止使用这两种药，无安全性数据。\n    \u003C/li>\n    \u003Cli>\n      儿童患者不属于常规适应症范畴，不建议使用。\n    \u003C/li>\n    \u003Cli>\n      免疫力低下或伴有严重感染时，不宜用药，避免加重不良反应。\n    \u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    \u003Cspan class=\"ovarian-guide-important\">特别提醒：\u003C/span>特殊人群每次用药前均需复查肝肾和血液指标，发现异常立即调整方案。\u003Cbr>\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 06 常见不良反应及处理方法 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img6\" style=\"background: linear-gradient(90deg, #f7f3ec 0%, #e9ecef 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与处理方法🔎\u003C/h2>\n  \u003Cp>\n    白蛋白紫杉醇和贝伐珠单抗常见的不良反应包括：骨髓抑制、恶心呕吐、脱发、高血压、蛋白尿等。以具体用药经验为例：患者在化疗期间出现中性粒细胞下降，医护人员临时延迟药物，恢复后再用药。\u003Cspan class=\"ovarian-guide-tip\">遇到类似症状切忌自行处理，必须由医生判断是否停药或更改方案。\u003C/span>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>白蛋白紫杉醇最常见困扰是脱发和外周神经病变。\u003C/li>\n    \u003Cli>贝伐珠单抗易致高血压、血栓或蛋白尿。\u003C/li>\n    \u003Cli>呕吐、乏力可用止吐药如甲氧氯普胺辅助缓解。\u003C/li>\n    \u003Cli>发生严重过敏反应或急性不适时，立即抢救并停药。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    临床数据（Burger et al., 2011；Pignata et al., 2015）显示，明显不良反应发生率可达50%，早发现、早处理能最大程度保障疗效与安全。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 07 储存方法与有效期管理 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img7\" style=\"background: linear-gradient(90deg, #e8f1f6 0%, #efeae3 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存条件与有效期⏳\u003C/h2>\n  \u003Cp>\n    再强调一次，抗肿瘤药品的储存极其关键。\u003Cbr>\n    \u003Cb>白蛋白紫杉醇\u003C/b>应储存于2-8℃冷藏箱，不可冷冻，避光密闭。配制后药液必须在当天用完。\u003Cbr>\n    \u003Cb>贝伐珠单抗\u003C/b>同样需冷藏，运输全程冷链监控。违反储存规定，药品效力降低甚至彻底失效。\n    \u003Cspan class=\"ovarian-guide-tip\">过期药品、外观异常均不可继续用药，必须按照医疗废弃物流程安全处置。\u003C/span>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>切勿家庭自行储存。\u003C/li>\n    \u003Cli>配药后定时检查剩余药品，一旦发现污染或变色，立刻报备。\u003C/li>\n    \u003Cli>药品使用期严格参照说明书规定，过期不可用。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003C!-- 08 漏服与过量：处理方法与防范措施 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img8\" style=\"background: linear-gradient(90deg, #f4f7fb 0%, #f3f7ee 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量：应急措施🚨\u003C/h2>\n  \u003Cp>\n    由于这类药品按周期静脉滴注，漏服等异常状况必须及时上报医护。\u003Cbr>\n    \u003Cspan class=\"ovarian-guide-important\">正确做法：\u003C/span>\n  \u003C/p>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>发现漏服——立即联系医生评估，切勿自行补药或更改剂量。\u003C/li>\n    \u003Cli>如不慎过量——立刻停药，同时监测生命体征，必要时住院处理。\u003C/li>\n    \u003Cli>出现中毒症状（如剧烈呕吐、高热、皮疹），迅速送医抢救。\u003C/li>\n  \u003C/ul>\n  \u003Cp>\n    实际工作中，每一例异常情况都需完善记录，有助于用药风险防控。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 09 日常管理与用药体验：临床案例总结 -->\n\u003Cdiv class=\"ovarian-guide-section bg-img9\" style=\"background: linear-gradient(90deg, #eaf7f2 0%, #efdde6 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 用药体验与临床总结📜\u003C/h2>\n  \u003Cp>\n    从临床实际来看，严格按周期、规范用药、重视储存与相互作用，是获得良好效果的前提。例如：\u003Cbr>\n    \u003Cb>有患者在使用贝伐珠单抗期间出现蛋白尿，通过调整用量和密切随访，最终未影响整体治疗方案。\u003C/b>\u003Cbr>\n    \u003Cb>另一位患者化疗联合用药后恶心加重，经及时加用止吐药后顺利完成疗程。\u003C/b>\u003Cbr>\n    真实用药体验说明，药品本身安全有效，但必须遵医嘱，不能自作主张。\n  \u003C/p>\n\u003C/div>\n\n\u003C!-- 10 总结：如何提高安全用药水平？ -->\n\u003Cdiv class=\"ovarian-guide-section bg-img10\" style=\"background: linear-gradient(90deg, #f7eeea 0%, #eef3f9 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 结语：牢记用药细节，安全用药才能更放心✅\u003C/h2>\n  \u003Cp>\n    白蛋白紫杉醇与贝伐珠单抗在抗肿瘤治疗中有着独特作用。安全用药的关键在于剂型规范、给药周期、相互作用管理、特殊人群调整、不良反应识别和标准储存。\u003Cbr>\n    \u003Cspan class=\"ovarian-guide-tip\">再次强调：\u003C/span>任何阶段都不建议自主更改用药方案、忽略监测或自行处理不良反应。💡如有疑问，第一时间咨询专业医护人员。安全用药，从关注细节开始。\n  \u003C/p>\n\u003C/div>\n\n\u003Cdiv class=\"ovarian-guide-section bg-img11\" style=\"background: linear-gradient(90deg, #f3fcf8 0%, #e6eefc 100%); margin-bottom:32px;\">\n  \u003Ch2 class=\"ovarian-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献与权威数据\u003C/h2>\n  \u003Cul class=\"ovarian-guide-list\">\n    \u003Cli>\n      Burger, R. A., et al. (2011). \"Incorporation of bevacizumab in the primary treatment of ovarian cancer.\" \u003Ci>New England Journal of Medicine\u003C/i>, 365(26), 2473–2483.\n    \u003C/li>\n    \u003Cli>\n      Pignata, S., et al. (2015). \"Chemotherapy and targeted therapy in the treatment of advanced ovarian cancer.\" \u003Ci>Critical Reviews in Oncology/Hematology\u003C/i>, 96(2), 368–379.\n    \u003C/li>\n    \u003Cli>\n      Armstrong, D. K., et al. (2006). \"Intravenous albumin-bound paclitaxel in cancer therapy: pharmacology and clinical experience.\" \u003Ci>Journal of Clinical Oncology\u003C/i>, 24(3), 339–345.\n    \u003C/li>\n    \u003Cli>\n      Ferrara, N., et al. (2004). \"Bevacizumab: anti-VEGF antibody for cancer therapy.\" \u003Ci>Biochemical and Biophysical Research Communications\u003C/i>, 333(2), 328–335.\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立样式，保证被嵌入页面不受影响 */\n.ovarian-guide-title {\n  font-size: 36px;\n  color: #523a74;\n  font-weight: bold;\n  text-align: center;\n  margin-top: 40px;\n  margin-bottom: 32px;\n  letter-spacing: 1px;\n  line-height: 1.3;\n  background: linear-gradient(90deg,#e7e2ee 0%, #fff 100%);\n  border-radius: 18px;\n  padding: 28px 0;\n  box-shadow: 0px 6px 16px rgba(134,128,173,0.06);\n}\n.ovarian-guide-h2 {\n  font-size: 26px;\n  color: #4a2669;\n  font-weight: 600;\n  margin-bottom: 18px;\n  margin-top: 0;\n  letter-spacing: 0.6px;\n  padding-top: 10px;\n}\n.ovarian-guide-section {\n  border-radius: 22px;\n  padding: 38px 36px 30px 36px;\n  box-shadow: 0px 4px 16px rgba(194,188,232,0.07);\n  margin: 0 auto 32px auto;\n  font-size: 19px;\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, Helvetica, sans-serif;\n  max-width: 1080px;\n  min-width: 340px;\n  line-height: 1.8;\n}\n.bg-soft { background: linear-gradient(90deg, #f9fafb 0%, #e3dde9 100%);}\n.bg-img1 { background: linear-gradient(90deg, #e7eee2 0%, #f3e7e0 100%);}\n.bg-img2 { background: linear-gradient(90deg, #e8eef5 0%, #ecfaf1 100%);}\n.bg-img3 { background: linear-gradient(90deg, #f2f5fb 0%, #f7efe6 100%);}\n.bg-img4 { background: linear-gradient(90deg, #edf2f5 0%, #f0efe7 100%);}\n.bg-img5 { background: linear-gradient(90deg, #f9f9ea 0%, #e7f3ee 100%);}\n.bg-img6 { background: linear-gradient(90deg, #f7f3ec 0%, #e9ecef 100%);}\n.bg-img7 { background: linear-gradient(90deg, #e8f1f6 0%, #efeae3 100%);}\n.bg-img8 { background: linear-gradient(90deg, #f4f7fb 0%, #f3f7ee 100%);}\n.bg-img9 { background: linear-gradient(90deg, #eaf7f2 0%, #efdde6 100%);}\n.bg-img10 { background: linear-gradient(90deg, #f7eeea 0%, #eef3f9 100%);}\n.bg-img11 { background: linear-gradient(90deg, #f3fcf8 0%, #e6eefc 100%);}\n.ovarian-guide-list {\n  margin: 16px 0 8px 20px;\n  padding-left: 8px;\n  font-size: 18px;\n}\n.ovarian-guide-list li {\n  margin-bottom: 10px;\n}\n.ovarian-guide-important {\n  color: #b7156d;\n  font-weight: 600;\n  padding-right: 4px;\n}\n.ovarian-guide-tip {\n  color: #2666a0;\n  font-weight: 500;\n  padding-left: 2px;\n}\n@media only screen and (max-width: 850px) {\n  .ovarian-guide-section {\n    padding: 24px 9vw 16px 6vw;\n    font-size: 17px;\n    max-width: 98vw;\n  }\n  .ovarian-guide-title {\n    font-size: 26px;\n    padding: 17px 0;\n  }\n  .ovarian-guide-h2 {\n    font-size: 20px;\n    padding-top: 6px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv id=\"material_title\" class=\"ovarian-guide-title\">\n  卵巢癌IV期治疗的科学指南：白蛋白紫杉醇与贝伐珠单抗的应用\n\u003C/div>\n\n\u003Cdiv c",504,"2025-09-23 14:07:09","卵巢癌, 白蛋白紫杉醇, 贝伐珠单抗, 治疗方案, 不良反应, 年龄因素, 药物相互作用","本文深入解析卵巢癌IV期治疗中白蛋白紫杉醇与贝伐珠单抗的关键用药细节，助您掌握用药安全与效果提升的科学要点。","2025-10-21 20:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]